JP2024506385A5 - - Google Patents
Info
- Publication number
- JP2024506385A5 JP2024506385A5 JP2023548874A JP2023548874A JP2024506385A5 JP 2024506385 A5 JP2024506385 A5 JP 2024506385A5 JP 2023548874 A JP2023548874 A JP 2023548874A JP 2023548874 A JP2023548874 A JP 2023548874A JP 2024506385 A5 JP2024506385 A5 JP 2024506385A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- gdc
- patient
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149944P | 2021-02-16 | 2021-02-16 | |
| US63/149,944 | 2021-02-16 | ||
| PCT/US2022/016270 WO2022177844A1 (en) | 2021-02-16 | 2022-02-14 | Treatment of breast cancer using combination therapies comprising gdc-9545 and gdc-0077 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506385A JP2024506385A (ja) | 2024-02-13 |
| JP2024506385A5 true JP2024506385A5 (https=) | 2025-02-18 |
Family
ID=80953424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548874A Pending JP2024506385A (ja) | 2021-02-16 | 2022-02-14 | Ｇｄｃ－９５４５及びｇｄｃ－００７７を含む併用療法を使用する乳がんの治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230381155A1 (https=) |
| EP (1) | EP4294395B1 (https=) |
| JP (1) | JP2024506385A (https=) |
| CN (1) | CN117377472A (https=) |
| ES (1) | ES3030540T3 (https=) |
| PL (1) | PL4294395T3 (https=) |
| TW (1) | TWI808648B (https=) |
| WO (1) | WO2022177844A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202541794A (zh) * | 2022-11-02 | 2025-11-01 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)之靶向別位及正位袋點 |
| JP2025163068A (ja) * | 2022-11-02 | 2025-10-28 | ペトラ・ファーマ・コーポレイション | 疾患の治療のためのホスホイノシチド３－キナーゼ（ｐｉ３ｋ）のアロステリックポケット及びオルソステリックポケットの標的化 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI874834B (zh) | 2014-12-18 | 2025-03-01 | 瑞士商赫孚孟拉羅股份公司 | 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途 |
| AU2016287463B2 (en) | 2015-07-02 | 2020-07-02 | F. Hoffmann-La Roche Ag | Benzoxazepin oxazolidinone compounds and methods of use |
| CN109843882A (zh) * | 2016-06-16 | 2019-06-04 | 豪夫迈·罗氏有限公司 | 四氢-吡啶并[3,4-b]吲哚雌激素受体调节剂及其用途 |
| CR20200621A (es) * | 2018-06-21 | 2021-02-03 | Hoffmann La Roche | Formas sólidas de 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3 fluoropropil)azetidin-3-il)amino)fenil)-3-(metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)-2,2-difluoropropan-1-ol y procesos para preparar compuestos tricíclicos fusionados que comprenden un resto fenilo o piridinilo sustituido, incluidos métodos para su uso |
| TW202011966A (zh) * | 2018-07-23 | 2020-04-01 | 瑞士商赫孚孟拉羅股份公司 | 用pi3k抑制劑gdc-0077治療癌症之方法 |
| JP7571006B2 (ja) | 2018-08-17 | 2024-10-22 | ジェネンテック， インコーポレイテッド | 乳がんの処置のための診断的および治療的方法 |
| CA3169679A1 (en) * | 2020-03-06 | 2021-09-10 | Olema Pharmaceuticals, Inc. | Methods of treating estrogen receptor-associated diseases |
-
2022
- 2022-02-14 TW TW111105232A patent/TWI808648B/zh active
- 2022-02-14 WO PCT/US2022/016270 patent/WO2022177844A1/en not_active Ceased
- 2022-02-14 ES ES22713478T patent/ES3030540T3/es active Active
- 2022-02-14 PL PL22713478.0T patent/PL4294395T3/pl unknown
- 2022-02-14 EP EP22713478.0A patent/EP4294395B1/en active Active
- 2022-02-14 JP JP2023548874A patent/JP2024506385A/ja active Pending
- 2022-02-14 CN CN202280015198.3A patent/CN117377472A/zh active Pending
-
2023
- 2023-08-15 US US18/449,800 patent/US20230381155A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024015120A5 (https=) | ||
| JP2022022264A5 (https=) | ||
| JP2023174661A5 (https=) | ||
| JP2022009090A5 (https=) | ||
| JP2022544485A5 (https=) | ||
| JP2022544234A5 (https=) | ||
| JP2022531898A5 (https=) | ||
| JP2012522837A5 (https=) | ||
| JP2024506385A5 (https=) | ||
| JP2019508476A5 (https=) | ||
| JP2018503610A5 (https=) | ||
| CN115135649A (zh) | 包括吡啶并[1,2-a]嘧啶酮化合物的药物组合 | |
| CN109985237A (zh) | 一种治疗结直肠癌的药物组合物及其应用 | |
| JP2021169534A5 (https=) | ||
| JP2022523045A5 (https=) | ||
| JP2024517085A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| JP2022543679A5 (https=) | ||
| JP2025509278A5 (https=) | ||
| TW202110448A (zh) | Ｐａｒｐ抑制劑聯合ｖｅｇｆｒ抑制劑用於治療卵巢癌或乳腺癌的用途 | |
| JP2024529430A5 (https=) | ||
| JP2024540044A5 (https=) | ||
| JP2022177119A5 (https=) | ||
| JP2024525164A5 (https=) |